US-based Camber Spine Technologies says that it has received 510(k) clearance from the US Food and Drug Administration (FDA) to market its SPIRA Open Matrix ALIF fusion spinal implant.
‘Camber Spine is very excited to be launching our first in a series of spinal implants using 3D printed - additive manufacturing,’ said Daniel Pontecorvo, CEO of Camber Spine. ‘This specialized manufacturing technology allows us to create these truly unique patented structures featuring open arched matrices and proprietary surfaces designed to enhance fusion and promote bone growth.’
This story is reprinted from material from Camber, with editorial changes made by Materials Today. The views expressed in this article do not necessarily represent those of Elsevier.
